G. OʼConnell

858 total citations
21 papers, 634 citations indexed

About

G. OʼConnell is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, G. OʼConnell has authored 21 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Reproductive Medicine, 6 papers in Public Health, Environmental and Occupational Health and 3 papers in Surgery. Recurrent topics in G. OʼConnell's work include Ovarian cancer diagnosis and treatment (10 papers), Reproductive Biology and Fertility (6 papers) and Endometrial and Cervical Cancer Treatments (2 papers). G. OʼConnell is often cited by papers focused on Ovarian cancer diagnosis and treatment (10 papers), Reproductive Biology and Fertility (6 papers) and Endometrial and Cervical Cancer Treatments (2 papers). G. OʼConnell collaborates with scholars based in Canada. G. OʼConnell's co-authors include John Jarrell, K. Swenerton, Kieran J. Murphy, Michel Préfontaine, Grant D. MacLean, Gavin Stuart, Pierre Drouin, J. Carmichael, Avril McMahon and Moni Roy and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and American Journal of Obstetrics and Gynecology.

In The Last Decade

G. OʼConnell

20 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. OʼConnell Canada 13 360 208 199 141 120 21 634
Malkasian Gd United States 16 495 1.4× 227 1.1× 228 1.1× 121 0.9× 80 0.7× 33 739
Murat Dede Türkiye 15 347 1.0× 198 1.0× 241 1.2× 61 0.4× 63 0.5× 77 649
J B Truc France 11 454 1.3× 202 1.0× 261 1.3× 99 0.7× 61 0.5× 13 701
T. Wade‐Evans United Kingdom 13 254 0.7× 166 0.8× 281 1.4× 79 0.6× 59 0.5× 22 793
Piver Ms United States 12 222 0.6× 115 0.6× 131 0.7× 130 0.9× 30 0.3× 43 440
Shashikant B. Lele United States 13 531 1.5× 255 1.2× 322 1.6× 118 0.8× 48 0.4× 29 699
Elizabeth Mussey United States 13 360 1.0× 143 0.7× 230 1.2× 119 0.8× 55 0.5× 25 637
Mauro Melpignano Italy 17 647 1.8× 265 1.3× 645 3.2× 132 0.9× 50 0.4× 34 966
Decker Dg United States 12 375 1.0× 154 0.7× 191 1.0× 136 1.0× 64 0.5× 22 598
Samet Topuz Türkiye 17 336 0.9× 153 0.7× 331 1.7× 93 0.7× 123 1.0× 89 726

Countries citing papers authored by G. OʼConnell

Since Specialization
Citations

This map shows the geographic impact of G. OʼConnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. OʼConnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. OʼConnell more than expected).

Fields of papers citing papers by G. OʼConnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. OʼConnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. OʼConnell. The network helps show where G. OʼConnell may publish in the future.

Co-authorship network of co-authors of G. OʼConnell

This figure shows the co-authorship network connecting the top 25 collaborators of G. OʼConnell. A scholar is included among the top collaborators of G. OʼConnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. OʼConnell. G. OʼConnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Warr, David, Peter Venner, Joseph L. Pater, et al.. (1993). A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. European Journal of Cancer. 29(1). 33–36. 29 indexed citations
3.
OʼConnell, G., et al.. (1993). A quantitative method for silica flux evaluation. Metallurgical Transactions B. 24(1). 63–73. 3 indexed citations
4.
Rusthoven, James J., E. Eisenhauer, J. Mazurka, et al.. (1993). Phase I Clinical Trial of Recombinant Human Interleukin-3 Combined With Carboplatin in the Treatment of Patients With Recurrent Ovarian Carcinoma. JNCI Journal of the National Cancer Institute. 85(10). 823–825. 11 indexed citations
5.
Hirte, Holger W., David A. Clark, G. OʼConnell, James J. Rusthoven, & J. Mazurka. (1992). Reversal of suppression of lymphokine-activated killer cells by transforming growth factor-β in ovarian carcinoma ascitic fluid requires interleukin-2 combined with anti-CD3 antibody. Cellular Immunology. 142(1). 207–216. 19 indexed citations
6.
Swenerton, K., Gavin Stuart, Moni Roy, et al.. (1992). Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 10(5). 718–726. 155 indexed citations
7.
Hirte, Hal W., et al.. (1992). A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma. Gynecologic Oncology. 44(3). 223–226. 22 indexed citations
8.
Covens, Allan, G. OʼConnell, James J. Rusthoven, & J. Mazurka. (1992). Phase II study of mitomycin C and 5 fluorouracil in platinum resistant ovarian cancer.. PubMed. 13(2). 125–30. 1 indexed citations
9.
Hirte, Hal W., et al.. (1992). A rapid and simple method for the purification of tumor cells from ascitic fluid of ovarian carcinoma. International Journal of Gynecology & Obstetrics. 39(4). 359–360. 1 indexed citations
10.
Colgan, Terence J., Irving Dardick, & G. OʼConnell. (1991). Paraganglioma of the Vulva. International Journal of Gynecological Pathology. 10(2). 203–208. 10 indexed citations
11.
Jarrell, John, et al.. (1991). The short-term reproductive toxicity of cyclophosphamide in the female rat. Reproductive Toxicology. 5(6). 481–485. 37 indexed citations
12.
Rusthoven, James J., Leslie Levin, J. Mazurka, et al.. (1991). Two Phase I Studies of Carboplatin Dose Escalation in Chemotherapy-Naive Ovarian Cancer Patients Supported With Patients Supported With Granulocyte-Macrophage Colony-Stimulating Factor. JNCI Journal of the National Cancer Institute. 83(23). 1748–1753. 23 indexed citations
13.
Rusthoven, James J., L Levin, E. Eisenhauer, et al.. (1991). A phase I study of GM-CSF, cyclophosphamide (CP), and escalating doses of carboplatin (CBDCA) in chemotherapy-Naïve patients with ovarian cancer. Gynecologic Oncology. 40(2). 169–170. 2 indexed citations
14.
Jarrell, John, et al.. (1989). The effect of medroxyprogesterone acetate (Provera) on ovarian radiosensitivity. American Journal of Obstetrics and Gynecology. 160(4). 990–994. 5 indexed citations
15.
Shelley, W, et al.. (1988). Toxicity of abdominopelvic radiation in advanced ovarian carcinoma patients after cisplatin/cyclophosphamide therapy and second-look laparotomy.. PubMed. 71(3 Pt 1). 327–32. 18 indexed citations
16.
Jarrell, John, E.V. YoungLai, Avril McMahon, et al.. (1987). Effects of ionizing radiation and pretreatment with [D-Leu6,des-Gly10] luteinizing hormone-releasing hormone ethylamide on developing rat ovarian follicles.. PubMed. 47(19). 5005–8. 15 indexed citations
17.
OʼConnell, G., Wendy Shelley, J. Carmichael, et al.. (1987). High-dose-intensity regimen of weekly doxorubicin and cisplatin in the treatment of patients with stage III and IV epithelial ovarian carcinoma.. PubMed. 71(5). 455–8. 3 indexed citations
18.
OʼConnell, G., et al.. (1987). Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.. PubMed. 70(6). 930–2. 68 indexed citations
19.
Jarrell, John, et al.. (1987). Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat.. PubMed. 47(9). 2340–3. 62 indexed citations
20.
Qizilbash, Ali H., et al.. (1985). Adenocarcinoma in a cecal neovagina—Complication of irradiation: Report of a case and review of literature. Gynecologic Oncology. 21(2). 235–239. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malkasian Gd Breakdown of academic impact, for papers by Murat Dede Breakdown of academic impact, for papers by J B Truc Breakdown of academic impact, for papers by T. Wade‐Evans Breakdown of academic impact, for papers by Piver Ms Breakdown of academic impact, for papers by Shashikant B. Lele Breakdown of academic impact, for papers by Elizabeth Mussey Breakdown of academic impact, for papers by Mauro Melpignano Breakdown of academic impact, for papers by Decker Dg Breakdown of academic impact, for papers by Samet Topuz
Rankless by CCL
2026